University of Evansville professor of psychology Mark Kopta has been awarded a patent by the United States Patent and Trademark Office for the CelestHealth System-MD, an electronic system that assesses the effects of medications across medical visits.
The system allows the physician to understand the treatment outcomes for an individual patient, all patients in the physician’s practice, and patients being treated by all medical practices using the system. It can assess medication effectiveness related to mental health, pain, tumor size, and blood chemistry.
Kopta’s CelestHealth Research Group continues to test the system at Johns Hopkins University.
